codman intracranial pressure icp microsensor probe (Johnson & Johnson)
86
Structured Review
Johnson & Johnson
codman intracranial pressure icp microsensor probe
Codman Intracranial Pressure Icp Microsensor Probe, supplied by Johnson & Johnson, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microsensor/icp+probe/pmc12540087-76-16-23
Average 86 stars, based on 1 article reviews
Codman Intracranial Pressure Icp Microsensor Probe, supplied by Johnson & Johnson, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microsensor/icp+probe/pmc12540087-76-16-23
Average 86 stars, based on 1 article reviews
codman intracranial pressure icp microsensor probe - by Bioz Stars,
2026-10
86/100 stars
Images
1) Product Images from "Posterior communicating artery vasospasm impairs cerebral pulsatility in an experimental subarachnoid hemorrhage model"
Article Title: Posterior communicating artery vasospasm impairs cerebral pulsatility in an experimental subarachnoid hemorrhage model
Journal: Frontiers in Neurology
doi: 10.3389/fneur.2025.1649577
Figure Legend Snippet: Representative intracranial pressure (ICP) waveforms in control, sham, and SAH groups. Waveforms are displayed in mmH₂O units and annotated with corresponding mean ± SD values derived from experimental data. Control and sham groups at day 1 demonstrated normal cardiac-synchronous pulsations (~99.0 ± 8.3 units). SAH animals exhibited markedly reduced amplitude on day 1 (~45.0 ± 4.9 units). By day 7, SAH animals showed partial recovery (~64.0 ± 1.5 units), though amplitudes remained lower than control and sham values at the same time point (~83 units).
Techniques Used: Control, Derivative Assay
Related Articles
other:Article Title: Posterior communicating artery vasospasm impairs cerebral pulsatility in an experimental subarachnoid hemorrhage model Article Snippet: Under general anesthesia, a small burr hole was created in the right parietal bone, and a Article Title: Modifying the ICP pulse wave: effects on parenchymal blood flow pulsatility. Article Snippet: An additional burr hole was manually drilled into the skull overlying the dorsolateral parietal cortex of each hemisphere, and the dura opened to implant an Article Title: Assessment of traumatic brain injury treatment guided by continuous monitoring of intracranial pressure and brain tissue oxygen partial pressure: A single-center pilot study. Article Snippet: Severe traumatic brain injury (TBI) is a leading cause of death and disability.. Monitoring intracranial pressure (ICP) is recommended, but the data on the outcomes are conflicting.. Adding continuous brain tissue oxygen partial pressure (PbtO2) monitoring may have some benefit but the OXY-TC suggested it did not improve 6month neurological outcomes. Article Title: Feasibility of assessing non-invasive intracranial compliance using FSI simulation-based and MR elastography-based brain stiffness Article Snippet: Subsequently, we inserted an Article Title: A mathematical framework for the dynamic interaction of pulsatile blood, brain, and cerebrospinal fluid. Article Snippet: Background: Shedding light on less-known aspects of intracranial fluid dynamics may be helpful to understand the hydrocephalus mechanism.. The present study suggests a mathematical framework based on in vivo inputs to compare the dynamic interaction of pulsatile blood, brain, and cerebrospinal fluid (CSF) between the healthy subject and the hydrocephalus patient.. Method: The input data for the mathematical formulations was pulsatile blood velocity, which was measured using cine PC-MRI. Article Title: Construction of nomogram model for early death risk in patients with severe traumatic brain injury Article Snippet: For those requiring ICP monitoring, we utilized an Biomarker Discovery:Article Title: Speech and Language Development, Hearing, and Feeding in Patients With Genetically Confirmed Crouzon Syndrome With Acanthosis Nigricans: A 36-Year Longitudinal Retrospective Review of Patients at the Oxford Craniofacial Unit Article Snippet: Objective: Crouzon syndrome with acanthosis nigricans (CAN) is caused by the specific mutation c.1172C>A (p.Ala391Glu) in the fibroblast growth factor receptor 3 gene, and has an estimated prevalence of 1:1,000,000 births.. Most cases occur de novo; however, autosomal dominant inheritance may occur.. The clinical presentation typically includes craniosynostosis, midface and maxillary hypoplasia, choanal atresia/stenosis, hydrocephalus, and intracranial hypertension. |